GV3
AH

Group VI 31’s Accretive Health AH Stock Holding History

Group VI 31’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.55M Hold
169,522
– – 100% 1
2013
Q2 		$1.83M Buy
+169,522
New +$1.78M 100% 1

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Group VI 31's AH Position: Q3 2013 in Review

Group VI 31 held its Accretive Health (AH) position steady in Q3 2013 at 169,522 shares worth $1.55M. The position accounts for 100% of the portfolio, ranked #1.

Group VI 31 first reported a position in AH in Q2 2013 and has held it in 2 quarters since. The position peaked at $1.83M in Q2 2013. 99 funds tracked by Wall St. Rank hold AH as of Q3 2013.

  • Group VI 31 held 169,522 shares of Accretive Health worth $1.55M as of Q3 2013.
  • Group VI 31 left its Accretive Health share count unchanged in Q3 2013.
  • Accretive Health made up 100% of Group VI 31's portfolio in Q3 2013, its #1 holding.
  • Group VI 31 first reported a position in Accretive Health in Q2 2013 and has held it in 2 quarters since.
  • Group VI 31's Accretive Health position peaked at $1.83M in Q2 2013.
  • 99 funds tracked by Wall St. Rank held Accretive Health as of Q3 2013.

Based on Group VI 31's 13F filing for Q3 2013, filed 13 Nov 2013.